Palvella Therapeutics
Michael Murray is currently an observer at Palvella Therapeutics. Prior to that, they worked as an associate at Leerink Partners LLC from September 2010 to May 2013. At Leerink, they worked with leading and emerging life sciences companies to develop and implement growth strategies.
This person is not in the org chart
This person is not in any offices
Palvella Therapeutics
Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases.